First Light Asset Management, LLC Amarin Corp Plcuk Transaction History

First Light Asset Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 16, 2021	SELL	$4.04 - $5.31 $9.03 Million - $11.9 Million	-2,236,158 Closed	0 $0
Q3 2020 Nov 13, 2020	BUY	$3.64 - $7.76 $4.22 Million - $9.01 Million	1,160,700 Added 107.93%	2,236,158 $9.41 Million
Q2 2020 Aug 14, 2020	BUY	$4.78 - $8.26 $1.52 Million - $2.62 Million	317,552 Added 41.9%	1,075,458 $7.44 Million
Q1 2020 May 15, 2020	BUY	$4.0 - $21.53 $1.2 Million - $6.45 Million	299,617 Added 65.38%	757,906 $3.03 Million
Q4 2019 Feb 14, 2020	SELL	$13.94 - $24.12 $6.42 Million - $11.1 Million	-460,557 Reduced 50.12%	458,289 $9.83 Million
Q3 2019 Nov 14, 2019	BUY	$13.89 - $23.16 $12.8 Million - $21.3 Million	918,846 New	918,846 $13.9 Million

176

65.1M

258K

98K

Ticker AMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 403,206,016
Market Cap $202M
Description
Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for r...

Get notified when there are updates to the investment portfolio of First Light Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on First Light Asset Management, LLC with notifications on news.